IFS (IFS) Stock Price & Analysis
IFS (IFS) rose 11.43% to USD 52.55 as of June 9, 2026 at 23:47 UTC, according to Nexqual real-time market data.
IFS last closed at USD 47.16; the session ranged USD 50.28–53.84 on volume of 706,990 shares. Market capitalization is $5.84B, with a 52-week range of USD 35.08–53.84 (NYQ). Source: Nexqual, June 9, 2026 at 23:47 UTC.
Key Statistics (as of June 9, 2026 at 23:47 UTC)
| Price | USD 52.55 |
|---|---|
| Change | ▲ 11.43% (up) |
| Previous Close | USD 47.16 |
| Open | USD 49.66 |
| Day Range | USD 50.28 – 53.84 |
| 52-Week Range | USD 35.08 – 53.84 |
| Volume | 706,990 shares |
| Market Cap | $5.84B |
| Exchange | NYQ |
Technical Analysis (IFS)
Nexqual's technical model rates IFS "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 9, 2026 at 23:47 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.91 (neutral) |
| vs SMA50 | Above (USD 47.78) |
| MACD | 0.78 (positive) |
Analyst Ratings (IFS)
Wall Street analysts rate IFS "None" based on 3 analysts, with a mean price target of USD 58.7 (range USD 51.66–67.86), per Nexqual as of June 9, 2026 at 23:47 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 58.7 |
| High Target | USD 67.86 |
| Low Target | USD 51.66 |
| Buy / Hold / Sell | 3 / 0 / 0 |
Earnings (IFS)
| Next Earnings Date | 2026-08-11 |
|---|---|
| EPS Estimate | USD 4.95 |
| Revenue Estimate | $1.54B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 5.39 vs est 4.76 ▲ beat |
| 2025-09-30 | USD 3.95 vs est 3.97 ▼ miss |
| 2025-06-30 | USD 5.14 vs est 3.85 ▲ beat |
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Financials & Fundamentals (IFS)
| Total Revenue | $5.81B |
|---|---|
| Revenue Growth (YoY) | +24.80% |
| Gross Margin | +0.00% |
| Operating Margin | +46.89% |
| Profit Margin | +35.92% |
| ROE | +17.97% |
| Total Cash | $7.35B |
| Total Debt | $14.29B |
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Financial Health Score (IFS)
Nexqual rates IFS's overall financial health "Weak" across five dimensions, as of June 9, 2026 at 23:47 UTC.
| Growth | Weak — Revenue -6% YoY (annual), declining |
|---|---|
| Profitability | Critical — Gross margin 0% |
| Balance Sheet | Mixed — $7.35B cash vs $14.3B debt |
| Cash Flow | Weak — Operating cash flow -$1.66B |
| Efficiency | Solid — ROE 18%, ROA 2.1% |
Ownership (IFS)
| Insider Ownership | +73.38% |
|---|---|
| Institutional Ownership | +24.41% |
| Shares Outstanding | 111.07M |
| Float | 29.50M |
| Short % of Float | +1.46% |
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Leadership (IFS)
IFS is led by Luis Felipe Castellanos Lopez-Torres B.B.A. (age 55), CEO & GM, per Nexqual as of June 9, 2026 at 23:47 UTC.
| CEO & GM | Luis Felipe Castellanos Lopez-Torres B.B.A. (age 55) |
|---|---|
| Chief Financial Officer | Michela Casassa Ramat B.B.A. (age 52) |
| Regional President For Southern, Western Europe & LATA | Andre Robberts |
Major Backers & Investors (IFS)
Notable institutional backers of IFS include FMR, LLC, Fidelity, Franklin Resources, Inc., according to Nexqual as of June 9, 2026 at 23:47 UTC.
Active Investors
| Investor | Stake |
|---|---|
| FMR, LLC | 1.63% |
| Fidelity | 1.29% |
| Franklin Resources, Inc. | 1.07% |
| Acadian Asset Management. LLC | 0.95% |
| Discovery Capital Management, LLC | 0.92% |
| NWI Management, L.P. | 0.89% |
| Schroder Investment Management Group | 0.69% |
| Millennium Management | 0.57% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 2.15% |
Source: Nexqual, June 9, 2026 at 23:47 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BAP | Credicorp Ltd. | USD 349.61 | ▲ 8.41% |
| BSAC | Banco Santander - Chile | USD 31.4 | ▲ 4.6% |
| CPAC | Cementos Pacasmayo S.A.A. | USD 10.42 | ▲ 0.19% |
| BCH | Banco De Chile | USD 38.54 | ▲ 5.65% |
| AVAL | Grupo Aval Acciones y Valores S | USD 5.09 | ▲ 6.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 23:47 UTC. This page is informational and not investment advice.